INDIA LIVE DESKNIFTY 50:23,140.50(+0.34%)SENSEX:73,895.74(+0.43%)
RDU Global
🇮🇳
Home/Topics/Companies & Institutions/Prozac
Back to Newsroom
🏢Organization Dossier

Prozac

Curated news coverage, institutional background, regulatory filings, and investigative reporting across RDU Global.

1 Stories Indexed
Last Updated: Just Now
Verified Entity Intelligence
World Politics & Diplomacy 11 Nov 2026, 05:00 PM IST

Escitalopram Found More Effective Than Prozac in Relapse Prevention, Analysis Shows

A large analysis has found that escitalopram, a widely prescribed antidepressant, outperformed Prozac in preventing relapse among many patients, adding fresh evidence to the debate over long-term treatment choices in major depressive disorder. The findings are likely to influence prescribing decisions as clinicians weigh efficacy, tolerability, and continuity of care for patients at high risk of recurrence.

By RDU Global Wire5 min read

🏢 About this Entity

Corporations, startups, regulatory bodies, central banks, ministries and judicial courts. All news mentioning this entity is automatically verified and aggregated into this live intelligence dossier.

Co-Occurring Entities

Entities frequently referenced alongside Prozac: